BioCentury
ARTICLE | Financial News

Cel-Sci completes private placement

February 24, 2017 2:18 AM UTC

On Feb. 17, cancer and infectious disease company Cel-Sci Corp. (NYSE-M:CVM) raised $1 million through the sale of 10 million shares at $0.10 in a registered direct offering to institutional investor...

BCIQ Company Profiles

Cel-Sci Corp.